Page 3 of 22

Currently one of the most common disease-causing bacterium in the world, Acinetobacter baumannii, for sure, is a nasty bug — an emerging nosocomial (hospital-associated) pathogen, being increasingly observed in serious conditions requiring intensive care (including ventilator-associated pneumonia, sepsis, meningitis, wound infection and urinary tract infection). Unfortunately for patients, particularly immune-suppressed ones, this bug is now known to be extensively drug resistant (XDR; resistant to most antibiotics including carbapenems, with the exception of two drugs of last resort, colistin and tigecycline), with a smaller proportion resistant to even these two (known as pan-drug resistant, PDR, which are therefore virtually untreatable with the current crop of FDA-approved medications).

The Forbes magazine has an impressive line-up of columnists; I follow many of those who write on the sciences and healthcare-related topics. One of them is Dr. David Kroll, a pharmacologist by profession and passionate, long-time science communicator. His column yesterday had especial interest for me; in it, David took the example of Dr. Derek Lowe—a pharmaceutical industry scientist who’s also a prolific and erudite blogger—who was apparently his inspiration for starting his own blog, and mentioned an intriguing thing Dr. Lowe had said during a Question and Answer session with Karen Weintraub for STAT News (quoting from David’s column including original links, below):

There is no denying the fact that visual representations —photos, graphics, and video— play a significant role in telling a story and conveying a concept. Even if the adage from early twentieth century, “a picture is worth a thousand words”, may have lost its charm a bit in this age of easy digital image/video manipulation, it’s not difficult to imagine why images and illustrations would have a tremendous impact in the communication of complex content, such as science communication. As James Balm (@JustBalmy), blogger and Social Media Assistant for BioMed Central, explained in an informative 2014 post:

Having been born and growing up in India, the land of the sacred cow, I am no stranger to this domesticated, quadrupedal ungulate of the subfamily Bovinae, genus Bos. It’s difficult not to have respect for an animal whose scientific name already proclaims it to be the boss, and I am culturally well-conditioned (‘well-done’, one might say) to accord an immediate reverence to this multi-faceted (not to mention, delectable) animal. After all, Gau-mata, or Cow the Mother, is an enduring socio-religious meme in India, stemming from simpler, more agrarian times — possibly a testament to the species’ intimate association with human history ever since it was domesticated about 10,500 years ago (archaeological and genetic evidence suggests that cows in Southeast Asia, Bos indicus, a different lineage from cows in Europe, were domesticated about 7000 years ago in the Harappan civilization).

Those who read my regular posts (Yes, that rare breed of people…) are amply aware that I am no fan of pseudoscience and quackery, as well as the relentless invasion of quackery into academia, leading invariably to scientifically implausible, nonsensical “research”, for which Dr. Harriet Hall had aptly coined the term “Tooth Fairy Science” several years ago over at Science Based Medicine.

It has been more than two years since I wrote about a tale of woe, the sad reality of being a non-immigrant biomedical researcher in the US. I chronicled the travails of my wife, who – even with a STEM PhD from a top-tier medical school in New York – was facing the murky uncertainties associated with doing science on a visa in the US. That uneasy disquietude still continues to haunt her; even though her Green Card application has been submitted, nothing is certain until she actually gets it in her hand – and we have no clue when that is going to happen.

Last month, PLOS One published a study which held significant interest for me; as a long time sufferer from acid reflux (which is currently reasonably controlled by regular use of a PPI – Proton-pump inhibitor – class of prescription antacid), I was curious to dive into this Randomized Controlled Trial (RCT) study from Beth Israel Deaconess in Boston, in which the investigators observed that Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease (GERD) as well as dyspepsia and other acid-reflux related issues, which affect 2-4 out of every 10 people in Western world (similar statistics were observed in the Northern part of India). The name of the study medication, Acidil, wasn’t immediately familiar to me, but it turned out to be a ‘homeopathic preparation’, which – along with the placebo-controlled designed – piqued my interest further. Although the severity of GERD symptoms may fluctuate due to different reasons, it is usually not one of those self-correcting conditions in which homeopaths often claim beneficial effect. So, sufficiently interested, I delved deeper.

The world of alternative medicine – nowadays more fashionably known as complementary and integrative medicine (CIM), replacing the erstwhile CAM (A = alternative) – encompasses a wide range of practices. Some of these practices involve physical motion of parts or whole of the body, such as massage, Yoga, and Tai Chi; if one subtracts the dollops of mysticism, especially of Eastern origin, that have come to be associated with these practices, one finds that they perform much of the same functions as any other regular exercise regimen, providing similar benefits. A few practices employ dietary supplements (vitamins, minerals, various salts, et cetera) and folk-remedies based on herbal medicine (Traditional Chinese Medicine/TCM, Ayurveda, Siddha, Unani, Amachi, and so forth) – some of which may and do contain biologically active substances, but the evidence for those being functional, safe, and effective therapeutic modalities in actual clinical situations is extremely scant, and the wide-ranging claims made by the practitioners are mostly never backed up by solid, scientific empirical methods. (Further reading: 1. Veteran ScienceBlogger Orac explains how the multi-billion dollar Supplements Industry takes their adoring clients for a ride; 2. I argue how the recent accolades for work stemming from the use of herbal medicine as a resource is not a context-less validation that herbalism works.)

Yesterday, on October 5, 2015, one half of the Nobel Prize in Physiology or Medicine was awarded to scientist and pharmaceutical chemist Tu Youyou (alternatively, Tu Yo Yo, 屠呦呦 in Chinese), for her discovery of the anti-malarial Artemisinin. (The other half went jointly to William C. Campbell and Satoshi Ōmura, for their discovery of a novel therapy for roundworm infection.)